<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The tie gene encodes a receptor tyrosine kinase that together with its thus far unidentified ligand appears to play a distinct role in the regulatory pathway of early hematopoiesis and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we attempted to define the possible involvement of tie in the pathobiology of <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> by examining tie <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in human <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
<SENT sid="2" pm="."><plain>We used a large panel of 93 well-characterized human continuous <z:hpo ids='HP_0001909'>leukemia</z:hpo>-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines as model systems for the various hematopoietic cell lineages </plain></SENT>
<SENT sid="3" pm="."><plain>At the Northern blot level, none of the 27 <z:hpo ids='HP_0005526'>lymphoid leukemia</z:hpo> or <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-derived cell lines (originating from four B-precursor <z:hpo ids='HP_0001909'>leukemia</z:hpo>, four B-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>, four B-cell non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, two <z:mp ids='MP_0009440'>myeloma</z:mp>, two Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, four T-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>, five Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, two anaplastic large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) tested expressed tie transcripts, whereas 23/42 (55%) of the myeloid cell lines analyzed expressed tie <z:chebi fb="2" ids="33699">mRNA</z:chebi>: in detail, 15 of 20 (75%) megakaryocytic, five of 11 (45%) erythroid, three of seven (43%) myelocytic and none of four monocytic cell lines were tie <z:chebi fb="2" ids="33699">mRNA</z:chebi> positive </plain></SENT>
<SENT sid="4" pm="."><plain>In the reverse transcriptase-polymerase chain reaction analysis, which can detect very low levels of <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression, <z:hpo ids='HP_0000001'>all</z:hpo> 12 myeloid cell lines and 19 of 39 (48%) lymphoid cell lines were positive </plain></SENT>
<SENT sid="5" pm="."><plain>In experiments aimed at inducing cellular differentiation over an incubation period of 4 days, the <z:chebi fb="0" ids="37532">phorbol ester</z:chebi> <z:chebi fb="1" ids="53780">PMA</z:chebi> strongly enhanced tie <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in one erythroid and in one myelocytic cell line, but (like thrombopoietin) down-regulated tie <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in two megakaryocytic cell lines </plain></SENT>
<SENT sid="6" pm="."><plain>Taken together these results indicate that tie is predominantly expressed in <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells derived from the myeloid cell lineages (and here in particular in megakaryoblastic cells) and not in <z:hpo ids='HP_0005526'>lymphoid leukemia</z:hpo> cells </plain></SENT>
<SENT sid="7" pm="."><plain>These observations provide some evidence for the hypothesis that tie is a receptor for a regulatory factor involved in <z:mpath ids='MPATH_458'>normal</z:mpath> and plausibly also leukemic hematopoiesis </plain></SENT>
</text></document>